SG Americas Securities’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,974
| Closed | -$32K | – | 2865 |
|
|
2025
Q1 | $32K | Sell |
14,974
-4,417
| -23% | -$9.44K | ﹤0.01% | 2922 |
|
|
2024
Q4 | $75K | Buy |
19,391
+5,042
| +35% | +$19.5K | ﹤0.01% | 2508 |
|
|
2024
Q3 | $94K | Buy |
+14,349
| New | +$94K | ﹤0.01% | 2756 |
|
|
2024
Q1 | – | Sell |
-14,159
| Closed | -$64K | – | 2815 |
|
|
2023
Q4 | $64K | Buy |
14,159
+3,039
| +27% | +$13.7K | ﹤0.01% | 2620 |
|
|
2023
Q3 | $44K | Buy |
+11,120
| New | +$44K | ﹤0.01% | 2661 |
|
|
2020
Q1 | – | Sell |
-1,792
| Closed | -$24K | – | 2938 |
|
|
2019
Q4 | $24K | Sell |
1,792
-61
| -3% | -$817 | ﹤0.01% | 2642 |
|
|
2019
Q3 | $16K | Sell |
1,853
-400
| -18% | -$3.45K | ﹤0.01% | 2425 |
|
|
2019
Q2 | $32K | Buy |
2,253
+954
| +73% | +$13.6K | ﹤0.01% | 2489 |
|
|
2019
Q1 | $43K | Buy |
+1,299
| New | +$43K | ﹤0.01% | 2771 |
|
|
2017
Q2 | – | Sell |
-935
| Closed | -$52K | – | 2837 |
|
|
2017
Q1 | $52K | Sell |
935
-20
| -2% | -$1.11K | ﹤0.01% | 2727 |
|
|
2016
Q4 | $36K | Buy |
+955
| New | +$36K | ﹤0.01% | 2571 |
|
|
2015
Q4 | – | Sell |
-594
| Closed | -$228K | – | 2340 |
|
|
2015
Q3 | $228K | Buy |
+594
| New | +$228K | ﹤0.01% | 1375 |
|
|
2015
Q1 | – | Sell |
-272
| Closed | -$101K | – | 2395 |
|
|
2014
Q4 | $101K | Buy |
+272
| New | +$101K | ﹤0.01% | 2611 |
|